Category: News This Week

  • Cigarette butts still toxic

    Cigarette butts still toxic

    Extinguished cigarette butts continue to release harmful toxins, reports News Medical Life Sciences, citing a new study.

    Dustin Poppendieck, a measurement scientist at the National Institute of Standards and Technology (NIST), and his team discovered that in one day, a used butt can give off the equivalent of up to 14 percent of the nicotine that an actively burning cigarette emits.

    Poppendieck and his team measured eight of the chemicals typically emitted from cigarettes as well as triacetin, a plasticizer often used to make cigarette filters stiff. Most of the chemicals were emitted in the first 24 hours, but nicotine and triacetin concentrations were still at about 50 percent of the initial level five days later. Butts emitted these chemicals at higher rates when the air temperature was higher.

    “The nicotine coming from a butt over seven days could be comparable to the nicotine emitted from mainstream and sidestream smoke during active smoking,” Poppendieck said.

    The NIST study was performed under an interagency agreement with the U.S. Food and Drug Administration.
     

     

  • FDA warns toothpick maker

    FDA warns toothpick maker

    The U.S. Food and Drug Administration (FDA) sent a warning letter to Smart Toothpicks for several violations of the Federal Food, Drug and Cosmetics Act.

    Smart Toothpicks is a company in Arizona that sells dissolvable tobacco products, including peppermint ice nicotine toothpicks.

    The FDA’s warning letter cited the company for three violations: selling a tobacco product to a minor through the company’s website; selling unauthorized modified-risk tobacco products; and failing to include required nicotine warning statements on both packaging and advertising. The FDA is requiring the company to respond in writing within 15 days outlining its plan for corrective actions and compliance with the Food, Drug and Cosmetics Act.

  • Hahn vows action if needed

    Hahn vows action if needed

    Stephen Hahn

    Stephen Hahn, the new U.S. Food and Drug Administration (FDA) commissioner, defended the Trump administration’s partial e-cigarette ban but said he would take more actions to stop teen vaping if necessary.

    The vaping ban will take effect on Feb. 6 and will ban the sale of most flavored cartridge-based vapor products, with the exception of menthol and tobacco flavors and single-use disposable products. Critics of the ban say it is too weak and fear youth will simply switch to the nonbanned products.

    In his first interview with a national media outlet since his confirmation in December, Hahn told the Washington Post that the sales restrictions will target the products most popular with youth but that the FDA will closely monitor the situation, and if minors do switch to menthol-flavored products, the agency will take further action to curb vaping.

    “The good thing about this policy is we have the ability without jumping through a lot of hoops to change our enforcement prioritization based on the data we are getting in,” Hahn said.

    Advocates on both sides expressed skepticism at the FDA’s ability to quickly assess and respond to changing patterns in youth vaping. “There is zero percent chance the FDA can quickly respond to what they view as the risks associated with vaping because in three years, they have failed to implement sensible regulations,” said Paul Blair, director of strategic initiatives for Americans for Tax Reform.

    “The agency’s record of monitoring the marketplace in real time is troubling,” said Matthew L. Myers, president of the Campaign for Tobacco-Free Kids. “There have been enormous changes with no evidence of their knowing it.”

  • Imperials appoints new CEO

    Imperials appoints new CEO

    Stefan Bomhard will join Imperial Brands’ board as chief executive officer effective at a date to be announced.

    “After a thorough search process, which attracted strong, high caliber interest, the board is delighted to appoint Stefan as chief executive of Imperial Brands,” said Therese Esperdy, chair of the board. “Stefan’s initial priorities will be to strengthen performance and enhance shareholder value.”

    “I’m delighted to be joining Imperial as the next chief executive,” said Bomhard. “I believe the business has a great future, and I’m looking forward to working with the group’s employees to maximize the opportunities that lie ahead and build a stronger, more sustainable business.”

    Bomhard was previously the chief executive of Inchcape, the president of Bacardi’s European region,  chief commercial officer of Cadbury, chief operating officer of Unilever Food Solutions Europe, and he held senior management and sales roles at Diageo and Proctor & Gamble. Bomhard has a PhD in marketing and is a nonexecutive director on the board of Compass Group.

    Following Bomhard’s appointment, Alison Cooper has stepped down as chief executive and board director effective immediately. Matthew Phillips has stepped down as chief development officer and board director effective immediately. Dominic Brisby, currently the divisional director for the Americas, Africa, Asia and Australasia, and Joerg Biebernick, the divisional director for Europe, will assume the roles of joint interim chief executive officers, reporting directly to Therese Esperdy until Bomhard assumes the CEO position.

  • Von Eicken turns 250

    Joh. Wilh. von Eicken celebrates its 250th anniversary in 2020.

    In 1770, Johann Wilhelm von Eicken founded a trading company in Germany for colonial goods. He quickly established close connections with the large trading centers in Europe. The company’s commercial activities centered on tobacco, which after a few decades led to the first tobacco factory.

    Throughout the years, the company defied wars, revolutions, inflation and increasing legal restrictions. More than once the fate of the company hung in the balance, but with a combination of farsightedness, courage and luck, Von Eicken grew into a globally operating tobacco company.

    Today, cigarettes, cigars, fine cut and pipe tobacco are produced in Luebeck and Dingelstaedt. Both facilities are certified in accordance with IFS Food Standard 6.1.

    Von Eicken is one of the last independent German family operations manufacturing cigarettes from raw tobacco through to the finished product.

    Current CEO Marc von Eicken is the eighth generation Von Eicken at the helm of the operation, which employs nearly 500 people. The company sells its brands in more than 100 countries, through its branches in France, the U.S., the United Arab Emirates and Singapore, and through long‐standing distribution partners around the world.

  • Strike in paper sector

    More than 9,000 Finnish paper mill workers, along with 6,000 employees at sawmills, plywood mills and other forestry plants, have been on strike since wage talks failed in late January, according to Reuters.

    Among the companies facing shutdowns are UPM Kymmene, Metsa Board and Stora Enso—all major packaging suppliers to the tobacco industry. While labor unions demand higher wages and fewer work hours, employers argue that the Finnish labor force is already expensive compared with that in other countries.

    Negotiations between the companies and employees continue. Employers warned, however, that if no agreement is reached by Feb. 10, they would start locking out workers from more than 10 production plants.

    The strikes could significantly impact the first-quarter results of all forestry companies on the Helsinki stock exchange, according to an analyst quoted by Bloomberg.

    The unrest in Finland’s forestry sectors follows a wave of labor conflicts in other sectors. The forestry industry is a major source of income for Finland.

     

     

     

  • Juul devalued again

    Juul devalued again

    Altria Group announced on Jan. 30 that it reduced its investment value in Juul Labs to around $12 billion, almost 70 percent less than the $38 billion valuation that Altria bought into in December 2018.

    Last October, Altria wrote down its Juul Labs stake by $4.5 billion followed by the $4.1 billion write down just announced.

    “I’m highly disappointed in the performance of our Juul investment,” said Altria CEO Howard Willard.

    According to Altria, the devaluation was driven by issues such as lawsuits, investigations into Juul’s marketing practices, flavored vapor product bans and a vaping health crisis.

    While Altria will no longer provide marketing and retail distribution for Juul Labs as originally agreed, it will now focus on helping Juul Labs with regulatory affairs, including the submission of its products for approval by the U.S. Food and Drug Administration.

  • IQOS MRTP under review

    IQOS MRTP under review

    The U.S. Food and Drug Administration (FDA) filed for scientific review modified-risk tobacco product (MRTP) applications from Philip Morris Products (PMP) for its IQOS heat-not-burn system and three types of HeatStick products on May 24, 2017.

    Due to the large size of these applications, the FDA is posting the application documents in installments on a rolling basis as they were redacted in accordance with applicable laws. The FDA completed posting the originally submitted applications on Nov. 28, 2017.

    The latest set of application materials from PMP was added on Jan. 24, 2020.

    The publicly available modules are located on the FDA’s website.

  • Doctors warm to e-cigs

    Doctors warm to e-cigs

    The Royal Australian College of General Practitioners (RACGP) said prescribing options for nicotine-replacement therapies should be widened, cautiously recommending e-cigarettes as a potential second-line quit-smoking aid, according to the “Supporting Smoking Cessation” guide.

    Nicholas Zwar, chairman of the advisory group behind the guide, said the recommendation that e-cigarettes could help people quit smoking came with many caveats. “The [therapies] that have been tested and been through therapeutic approval would be the first choice, but if you have someone who has not succeeded in quitting using those methods and they are interested in nicotine vaping, there is some evidence of benefit, and they could be considered,” he said.

    Zwar said using e-cigarettes is probably safer than smoking since e-cigarettes do not have the large number of toxic combustibles and carcinogens found in cigarettes. He also said the long-term health effects of vaping were not clear, but when considered in relation to helping people stop smoking it “can be considered” as a potential aid.

    Nicotine-replacement therapies are the first line of aid for those looking to quit smoking in Australia. However, currently, patients can only be prescribed one nicotine-replacement therapy at a time for a maximum of 12 weeks a year. “Rather than have patients [attempt to quit smoking] once a year, it would be much better if we were able to prescribe and patients receive subsidized treatment more than once a year,” said Harry Nespolon, RACGP president.

  • PMI and KT&G sign deal

    PMI and KT&G sign deal

    Philip Morris International (PMI) will commercialize KT&G’s smoke-free products outside of South Korea under the terms of a new agreement.

    “To achieve PMI’s vision of a smoke-free future, we must grow the smoke-free category worldwide, which requires multiple players providing a wide array of better choices for adult smokers,” said Andre Calantzopoulos, PMI’s CEO. “While IQOS continues to be the leading product in the smoke-free category, and we plan to broaden our portfolio by launching IQOS MESH in the coming months, we believe that increased collaboration will benefit adult smokers by providing greater choice and drive accelerated adoption of smoke-free products worldwide.”

    The agreement will run for an initial period of three years, allowing PMI to distribute current KT&G smoke-free products and their evolutions on an exclusive basis. It does not restrict PMI from distributing its own or third-party products.

    KT&G is the leading tobacco and nicotine company in South Korea. Its smoke-free products include heat-not-burn tobacco systems (Lil Mini and Lil Plus), hybrid technologies that combine heat-not-burn tobacco and e-vapor technologies (Lil Hybrid) and e-vapor products (Lil Vapor).

    PMI and KT&G will seek any necessary regulatory approvals for products that may be required on a market-by-market basis.

    The agreement does not pertain to combustible products. There are no current plans to commercialize KT&G products in the U.S.